Position
Chief Operating Officer
Company
Solu Therapeutics
BostonBiotechnologyHealth CareTherapeuticsDescription
Solu Therapeutics announced the appointment of Enda Moran, PhD, MBA as Chief Operating Officer (COO). His extensive experience in biomanufacturing and operations will be crucial as the company progresses with its clinical trials and develops transformative therapies.
Quick answer
Solu Therapeutics Appoints Enda Moran as Chief Operating Officer (June 16, 2025). Solu Therapeutics is based in Boston, Massachusetts, United States.
- Who is the new Chief Operating Officer at Solu Therapeutics?
- Solu Therapeutics named Enda Moran Chief Operating Officer, announced June 16, 2025.
- What did Solu Therapeutics announce on June 16, 2025?
- Solu Therapeutics announced the appointment of Enda Moran, PhD, MBA as Chief Operating Officer (COO). His extensive experience in biomanufacturing and operations will be crucial as the company progresses with its clinical trials and develops transformative therapies.
- What does Solu Therapeutics do?
- Solu Therapeutics, a precision-medicine company, is developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity.
- Where is Solu Therapeutics based?
- Solu Therapeutics is based in Boston, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- TOLREMO therapeutics (June 18, 2025), Atalanta Therapeutics (June 18, 2025), Alnylam Pharmaceuticals (June 19, 2025) and Vivex Biologics (June 10, 2025) also announced leadership changes within 45 days of Solu Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- TOLREMO Appoints Florian D. Vogl as Chief Medical Officer (June 18, 2025)
- Atalanta Therapeutics Appoints Joanne Kotz as Chief Executive Officer and Douglas Pagán as Chief Financial Officer & Chief Operating Officer (June 18, 2025)
- Alnylam Pharmaceuticals Appoints Pushkal Garg as Chief Research and Development Officer (June 19, 2025)
- Vivex Biologics Appoints Jon E. Block as Chief Clinical Officer (June 10, 2025)
- Lyell Immunopharma Appoints David Shook as Chief Medical Officer and Mark Meltz as General Counsel (June 9, 2025)
- Cure Rare Disease Appoints Keith Sutton as Chief Science Officer (June 9, 2025)
Who to call at Solu Therapeutics, and when
A new leader at Solu Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Solu Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Solu Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Solu Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Solu Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Solu Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.